Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 262 to 311 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3b1. [source:refseq;acc:nm\_006041]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.421\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
196.978\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11394\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl  3-o-sulfotransferase 2; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006043]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mrna decapping enzyme; histidine triad protein member 5; heat shock-like protein 1. [source:refseq;acc:nm\_014026]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.217\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.459\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11241\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional co-repressor sin3a; transcriptional regulator, sin3a (yeast). [source:refseq;acc:nm\_015477]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
241.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
267.88\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11121\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
density-regulated protein (drp) (drp1 protein) (smooth muscle cell associated protein-3) (smap-3). [source:swissprot;acc:o43583]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5 (eif-5). [source:swissprot;acc:p55010]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
271.016\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
244.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10996\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
241.373\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
267.352\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10763\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ligatin (hepatocellular carcinoma-associated antigen 56). [source:swissprot;acc:p41214]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10665\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s11. [source:swissprot;acc:p04643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.399\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
252.644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
252.512\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10578\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l17 (l23). [source:swissprot;acc:p18621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.808\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10557\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
252.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.828\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10552\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.235\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10541\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
285\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.647\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.242\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
286\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.633\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1052\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
240.758\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
266.078\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
289\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
272.781\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.892\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10486\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
231.969\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.064\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
251.679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.037\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.414\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10357\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
293\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
240.782\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
265.717\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
294\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [source:refseq;acc:nm\_016567]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
295\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.273\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.423\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.103\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
296\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l4 isoform a. [source:refseq;acc:nm\_015956]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
241.282\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
297\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l7. [source:swissprot;acc:p18124]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
235.727\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
259.984\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1029\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
298\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
268.632\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.588\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
299\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
268.635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.592\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
300\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
150.959\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10196\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1,4 mannosyltransferase. [source:refseq;acc:nm\_019109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
150.982\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.372\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
302\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l26. [source:swissprot;acc:q02877]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
242.326\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10185\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l35. [source:swissprot;acc:p42766]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
242.333\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.999\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15 (rig protein). [source:swissprot;acc:p11174]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
242.339\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
266.986\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1017\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
305\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l2. [source:refseq;acc:nm\_015950]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l14 (cag-isl 7). [source:swissprot;acc:p50914]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
242.153\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
266.673\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
307\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine racemase (ec 5.1.1.-). [source:swissprot;acc:q9gzt4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l34. [source:swissprot;acc:p49207]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 2 (sec61 alpha- 2). [source:swissprot;acc:q9y2r3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 1 (sec61 alpha- 1). [source:swissprot;acc:p38378]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
242.627\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.151\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10108\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/